Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.81 |
| ▸ | ESR1 | P03372 | 2/20 | 0.53 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.53 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.53 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.52 |
| ▸ | NQO2 | P16083 | 1/20 | 0.52 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.48 |
| ▸ | PLAU | P00749 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1-Naphthol SCHEMBL94756 | 1.00 | CYP1A2 (0.81) | CYP1A2ESR1ESR2HSD17B1HSD17B2 | |
| 1-Naphthol SCHEMBL28448239 | 1.00 | CYP1A2 (0.81) | CYP1A2ESR1ESR2HSD17B1HSD17B2 | |
| 1-Naphthol SCHEMBL6449294 | 0.94 | CYP1A2 (0.71) | CYP1A2ESR1ESR2HSD17B1HSD17B2 | |
| Biphenyl SCHEMBL28506877 | 0.94 | CYP1A2 (0.71) | CYP1A2ESR1ESR2HSD17B1HSD17B2 | |
| 1-Naphthol SCHEMBL3416 | 0.90 | CYP1A2 (1.00) | CYP1A2ESR1ESR2HSD17B1HSD17B2 | |
| 1-Naphthol SCHEMBL29767730 | 0.90 | CYP1A2 (1.00) | CYP1A2ESR1ESR2HSD17B1HSD17B2 | |
| 1-Naphthol SCHEMBL10486461 | 0.90 | CYP1A2 (1.00) | CYP1A2ESR1ESR2HSD17B1HSD17B2 | |
| 1-Naphthol SCHEMBL273260 | 0.90 | CYP1A2 (1.00) | CYP1A2ESR1ESR2HSD17B1HSD17B2 | |
| 1-Naphthol SCHEMBL11250007 | 0.88 | CYP1A2 (0.77) | CYP1A2ESR1ESR2HSD17B1HSD17B2 | |
| Phenol SCHEMBL8526528 | 0.87 | IDO1 (0.63) | CYP1A2ESR1ESR2HSD17B1HSD17B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320180-A1 | HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT | DIC CORPORATION (JP) | 2025-10-16 | — | — | US | disclosed |
| US-20250277081-A1 | GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED OBJECT, AND LAMINATE | DIC CORPORATION (JP) | 2025-09-04 | — | — | US | disclosed |
| US-20250277080-A1 | PHENOLIC HYDROXY GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC CORPORATION (JP) | 2025-09-04 | — | — | US | disclosed |
| US-20250223396-A1 | GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC CORPORATION (JP) | 2025-07-10 | — | — | US | disclosed |
| US-20250179237-A1 | GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC CORPORATION (JP) | 2025-06-05 | — | — | US | disclosed |
| EP-4527834-A1 | GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED OBJECT, AND LAMINATE | DIC Corporation (JP) | 2025-03-26 | — | — | EP | disclosed |
| EP-4527839-A1 | PHENOLIC HYDROXY GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC Corporation (JP) | 2025-03-26 | — | — | EP | disclosed |
| EP-4527832-A1 | HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT | DIC Corporation (JP) | 2025-03-26 | — | — | EP | disclosed |
| EP-4527870-A1 | GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC Corporation (JP) | 2025-03-26 | — | — | EP | disclosed |
| EP-4527869-A1 | GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE | DIC Corporation (JP) | 2025-03-26 | — | — | EP | disclosed |
| WO-2023171514-A1 | LAMINATE AND PACKAGING MATERIAL | DIC株式会社 | 2023-09-14 | — | — | WO | disclosed |
| WO-2022202781-A1 | THERMOSETTING RESIN COMPOSITION, HIGH FREQUENCY DEVICE, DIELECTRIC SUBSTRATE, AND MICROSTRIP ANTENNA | 住友ベークライト株式会社 | 2022-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250320180-A1 | HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT | RAD51, SEM1, GFER | CYP1A2 865/4885ESR1 1003/4885ESR2 996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.